EMA – La prima terapia orale con GLP-1 per il diabete mellito 2
31/01/2020
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial
Gerstein HC, Hart R, Colhoun HM, et al.
Lancet Diabetes Endocrinol. 2020;8(2):106-14
Leggi
Smoking cessation and weight change in relation to cardiovascular disease incidence and mortality in people with type 2 diabetes: a population-based cohort study
Liu G, Hu Y, Zong G, et al.
Lancet Diabetes Endocrinol. 2020;8(2):125-33
Leggi
Diabetes: a metabolic and reproductive disorder in women
Thong EP, Codner E, Laven JSE, Teede H
Lancet Diabetes Endocrinol. 2020;8(2):134-49
Leggi
Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study
Li Y, Schoufour J, Wang DD, et al.
BMJ. 2020;368 :l6669
Leggi
Distinct Metabolic Profile in Early Pregnancy of Overweight and Obese Women Developing Gestational Diabetes
Mokkala K, Vahlberg T , Pellonperä O, et al.
J Nutr. 2020;150(1):31-7
Leggi
Positioning time in range in diabetes management
Advani A
Diabetologia. 2020;63:242-52
Leggi
Relationship between hypoglycaemia, cardiovascular outcomes, and empagliflozin treatment in the EMPA-REG OUTCOME® trial
Fitchett D, Inzucchi SE, Wanner C, et al.
Eur Heart J. 2020;41(2):209-17
Leggi
A new perspective on lowering CV risk from hypoglycaemia
Solis-Herrera C, Sheikh O, Chilton R
Eur Heart J. 2020;41(2):218-20
Leggi
Autoimmunity plays a role in the onset of diabetes after 40 years of age
Rolandsson O, Hampe CS, Sharp SJ, et al.
Diabetologia. 2020;63:266-77
Leggi